Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Inventory (2016 - 2025)

Historic Inventory for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to $266000.0.

  • ProPhase Labs' Inventory fell 9329.3% to $266000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $266000.0, marking a year-over-year decrease of 9329.3%. This contributed to the annual value of $1.1 million for FY2024, which is 5010.91% down from last year.
  • According to the latest figures from Q3 2025, ProPhase Labs' Inventory is $266000.0, which was down 9329.3% from $830000.0 recorded in Q2 2025.
  • ProPhase Labs' 5-year Inventory high stood at $16.0 million for Q1 2021, and its period low was $266000.0 during Q3 2025.
  • Moreover, its 5-year median value for Inventory was $4.0 million (2022), whereas its average is $4.9 million.
  • In the last 5 years, ProPhase Labs' Inventory soared by 84104.52% in 2021 and then tumbled by 9329.3% in 2025.
  • ProPhase Labs' Inventory (Quarter) stood at $4.6 million in 2021, then decreased by 13.57% to $4.0 million in 2022, then tumbled by 42.38% to $2.3 million in 2023, then plummeted by 50.11% to $1.1 million in 2024, then crashed by 76.73% to $266000.0 in 2025.
  • Its last three reported values are $266000.0 in Q3 2025, $830000.0 for Q2 2025, and $1.1 million during Q1 2025.